Patients with SHH-driven medulloblastoma frequently exhibit either germline or somatic mutations and copy-number alterations in genes that regulate the Hedgehog (HH) signalling pathway such as PTCH1, SUFU, SMO, GLI1, GLI2 and MYCN8. Here, SMO is linked to medulloblastoma.